Medicinal and injection therapies for mechanical neck disorders

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Peloso, Paul Michael ^a   Gross, A ^a   Haines, T ^a   Trinh, K ^a   Goldsmith, C H ^a   Burnie, S ^a  

^a NONE

Author keywords

Anesthetics, local *administration dosage ; Anti inflammatory agents, non steroidal *administration dosage ; Botulinum toxin type A administration dosage ; Chronic disease; Lidocaine administration dosage

Indexed keywords

AMITRIPTYLINE; ANESTHETIC AGENT; BETAMETHASONE; BOTULINUM TOXIN A; BUPIVACAINE; CORTICOSTEROID; CYCLOBENZAPRINE; DIAZEPAM; EPERISONE; FLUOXETINE; GLAFENINE; GLUCOCORTICOID; LIDOCAINE; LYSININE CLONIXIMATE; MELATONIN; MEPROBAMATE; METHYLPREDNISOLONE; MORPHINE; MULTIVITAMIN; MUSCLE RELAXANT AGENT; MYONAL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENOBARBITAL; PRILOCAINE; PSYCHOTROPIC AGENT; STEROID; TETRAZEPAM; TRIAMCINOLONE; TRIAMCINOLONE ACETATE; UNINDEXED DRUG;

ACUPUNCTURE; ALLERGIC REACTION; ANTICHOLINERGIC EFFECT; BURN; CLINICAL TRIAL; DISABILITY; DIZZINESS; DROWSINESS; DRUG COST; DYSPEPSIA; FATIGUE; FLU LIKE SYNDROME; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH CARE COST; HUMAN; INDIGESTION; INJECTION SITE DISCOMFORT; INJECTION SITE PAIN; MANIPULATIVE MEDICINE; MECHANICAL NECK DISORDER; META ANALYSIS; MUSCLE SPASM; MUSCLE STRETCHING; MYALGIA; MYOFASCIAL PAIN; NAUSEA; NECK INJURY; NECK PAIN; NERVE BLOCK; PAIN; PAIN ASSESSMENT; PARESTHESIA; PHYSIOTHERAPY; PRURITUS; REVIEW; SIDE EFFECT; SKIN IRRITATION; SOMNOLENCE; SYSTEMATIC REVIEW; ULCER; VERTIGO; WHIPLASH INJURY; XEROSTOMIA;

EID: 44949102362     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000319.pub4     Document Type: Review

References (213)

1. Barnsley 1994 {published data only} *Barnsley L, Lord SM, Wallis BJ, Bogduk N. Lack of effect of intraarticular corticosteroids for chronic pain in the cervical zygapophysial joints. The New England Journal of Medicine 1994;330(15):1047-50.
2. Basmajian 1978 {published data only} *Basmajian JV. Cyclobenzaprine Hydrochloride Effect on Skeletal Muscle Spasm in the Lumbar Region and Neck: Two Double-Blind Controlled Clinical and Laboratory Studies. Archives of Physical Medicine Rehabilation 1978;59:58-63.
3. Basmajian 1978(CvD) {published data only} refer to Basmajian 1978.
4. Basmajian 1978(CvPl) {published data only} refer to Basmajian 1978.
5. Basmajian 1978(DvC) {published data only} refer to Basmajian 1978.
6. Basmajian 1978(DvPl) {published data only} refer to Basmajian 1978.
7. Basmajian 1983 {published data only} *Basmajian JV. Reflex cervical muscle spasm: Treatment by Diazepam, Phenobarbital or placebo. Archives of Physical Medicine Rehabilitation 1983;64:121-4.
8. Basmajian 1983(DvPh) {published data only} refer to Basmajian 1983.
9. Basmajian 1983(DvPl) {published data only} refer to Basmajian 1983.
10. Basmajian 1983(PhvD) {published data only} refer to Basmajian 1983.
11. Basmajian 1983(PhvPl) {published data only} refer to Basmajian 1983.
12. Bose 1999 {published data only} *Bose K. The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial. Methods Find Expeimental Clinical Pharmacology 1999;21(3):209-13.
13. Brockow 2001 {published data only} *Brockow T, Dillner A, Franke A, Resch KL. Analgesic effectiveness of subcutaneous carbon-dioxide insufflations as an adjunct treatment in patients with non-specific neck or low back pain. Complementary Therapies in Medicine 2001;9:68-76.
14. Castagnera 1994 {published data only} Castagnera L, Maurette P, Pointellart V, Vital JM, Erny P, Stenegas J. Long-term results of cervical epidural steroid injection with and without morphine in chronic cervical radicular pain. Pain 1994;58:239-43.
15. Cheshire 1994 (50U) {published data only} *Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994;59:65-9.
16. Choffray 1987 {published data only} * Choffray DU, Crielaard JM, Albert A, Franchimont P.Comparative study of high bio-availability glaphenine and paracetamol in cervical and lumbar arthrosis. Clinical Rheumatology 1987;6(4):518-25.
17. Dennert 1976 {published data only} *Dennert VR, Munzenberg KJ, Haase W. [Zur therapie der Zerviko-Brachialgie, Controllierter klinischer vergleich einer hochdosierten kombination neurotroper Vitamine mit einem Analgetikum]. Fortschritte der Medizin 1976;94(10):595-8.
18. Dostal 1978 {published data only} *Dostal C, Pavelka K, Lewit K. [Ibuprofen v lecbe cervickokranialniho syndromu v kombinaci manipulacni lecbou]. Fysiatricky vestnik 1978;56(5):258-63.
19. Esenyel 2000 {published data only} *Esenyel M, Caglar N, Aldemir T. Treatment of myofascial pain. American Journal of Physical Medicine and Rehabilitation 2000;79(1):48-52.
20. Esenyel 2000 (IMvUS) {published data only} refer to Esynyel 2000.
21. Esenyel 2000(IMvCnt) {published data only} refer to Esynel 2000.
22. Ferrante 1998 {published data only} *Ferrante FM, Kaufman AG, Dunbar SA, Cain CF, Cherukuri S. Sphenopalatine ganglion block for the treatment of myofascial pain of the head, neck and shoulders. Regional Anesthesia and Pain Medicine 1998;23(1):30-6.
23. Ferrante 2005 {published data only} Ferrante FM, Bearn L, Rothrock R, King L. Evidence against trigger point injection for the treatment of cervicotheroacic myofascial pain with botulinum toxin type A. Anesthesiology 2005;103(2):377-83.
24. Ferrante 2005 (10U) {published data only} refer to Ferrante 2005.
25. Ferrante 2005 (25U) {published data only} refer to Ferrante 2005.
26. Ferrante 2005 (50U) {published data only} refer to Ferrante 2005.
27. Freund 2000 (100U) {published data only} Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with Botulinum Toxin-A: A pilot study. Headache 2000;40:231-6.
28. *Freund BJ, Schwartz M. Treatment of whiplash associated neck pain with Botulinum Toxin-A: A pilot study. Journal of Rheumatology 2000;27:481-4.
29. Giles 1999 {published data only} *Giles LG, Muller R. Chronic spinal pain syndromes: A clinical pilot trial comparing acupuncture, a nonsteroidal anti-inflammatory drug, and spinal manipulation. Journal of Manipulative and Physiological Therapeutics 1999;22(6):376-81.
30. Giles 1999(MedvAcup) {published data only} refer to Giles 1999.
31. Giles1999(MedvManip) {published data only} refer to Giles 1999.
32. Ginsberg 1980 {published data only} *Ginsbert F, Famaey JP. Double-blind study of tolmetin vs naproxen in the treatment of cervical and lumbar osteoarthritis. Current Therapeutic Research 1980;26(5):622-9.
33. Heikkila 2000 {published data only} *Heikkila H, Johansson M, Wenngren BI. Effects of acupuncture, cervical manipulation and NSAID therapy of dizziness and impaired head repositioning of suspected cervical origin: A pilot study. Manual Therapy 2000;5(3):151-7.
34. Hong 1994 {published data only} *Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point: The importance of the local twitch response. American Journal of Physical Medicine and Rehabilitation 1994;73(4):256-63.
35. Inan 2001 {published data only} *Inan N, Ceyhan A, Inan L, Kavaklioglu O, Alptekin A, Unal N. C2/C3 Nerve blocks and greater occipital nerve block in cervicogenic headache treatment. Functional Neurology 2001;16(3):239-43.
36. Kamanli 2005 {published data only} *Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Ozkurt Zenigin F, Bayik Y. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points inmyofascial pain syndrome. Rheumatology International 2005;25:604-11.
37. Kamanli (BTX v DNG) {published data only} refer to Kamanli 2005.
38. Kamanli (BTX v LIG) {published data only} refer to Kamanli 2005.
39. Kamanli (LIG v BTX) {published data only} refer to Kamanli 2005.
40. Kamanli (LIG v DNG) {published data only} refer to Kamanli 2005.
41. Koes 1992 {published data only} Koes B. Efficacy of manual therapy and physiotherapy for back and neck complaints. (thesis) Den Haag: Cip-Gegevens Koninklijke Bibliotheek 1992a: Chapter 5, Table 6.
42. Koes BW. A randomized clinical trial of manual therapy and physiotherapy for persistent back and neck complaints. Subgroup analysis and relationship between outcomes measure. Journal of Manipulative and Physiological Therapeutics 1993;16(4):211-19.
43. Koes BW, Bouter LM, Knipshild PG. The effectiveness of manual therapy, physiotherapy and continued treatment by general practitioner for chronic nonspecific back and neck complaints. Journal of Manipulative and Physiological Therapeutics 1991;14:498-502. [MEDLINE: c01997].
44. Koes BW, Bouter LM, van Mameren H, Esser AH, Verstegen GH, Hofhuizen DM, et al.Randomized clinical trial of manual therapy and physiotherapy for persistent back and neck complaints. Manual Therapy in the Netherlands 1992d;1:7-12.
45. Koes BW, Bouter LM, van Mameren H, Esser AH, Verstegen GM, Hofhuizen DM, et al.A blind randomized clinical trial of manual therapy and physiotherapy for chronic back and neck complaints: Physical outcome measures. Journal of Manipulative Physiological Therapeutics 1992e;15(1):16-23.
46. *Koes BW, Bouter LM, van Mameren H, Esser AH, Verstegen GM, Hofhuizen DM, et al.Randomized clinical trial of manipulative therapy and physiotherapy for persistent back and neck complaints: results of one year follow up. British Medical Journal 1992b;304:601-5.
47. Koes BW, Bouter LM, van Mameren H, Esser AHM, Verstegen GMJR, Hofhuizen DM, et al.The effectiveness of manual therapy, physiotherapy, and treatment by the general practitioner for nonspecific back and neck complaints. Spine 1992c;17(1):28-35.
48. Koes 1992 (GP v MT) {published data only} refer to Koes 1992.
49. Koes 1992 (GP v Pl) {published data only} refer to Koes 1992.
50. Koes 1992 (GP v PT) {published data only} refer to Koes 1992.
51. McReynolds 2005 {published data only} *McReynolds TM, Sheridan BJ. Intramuscular Ketorlac versus osteopathic manipulative treatment in the management of acute neck pain in the emergency department: A randomized clinical trial. Journal of American Osteopathic Association 2005;105(2):57-68.
52. Nasswetter 1998 {published data only} *Nasswetter G, de los Santos AR, Marti ML, Girolamo GD. [Asociacion de Clonixinato de Lisina con Ciclobenzaprina en afecciones dolorosas del raquis con contractura muscular]. Prensa Medica Argentina 1998;85:507-14.
53. Payne 1964 {published data only} *Payne RW, Sorenson EJ, Smalley TK, Brandt EN. Diazepam, meprobamate and placebo in musculoskeletal disorders. Journal of American Medical Association 1964;188(3): 157-60.
54. Petterson 1998 {published data only} *Pettersson K, Toolanen G. High-dose methylprednisolone prevents extensive sick leave after whiplash injury, A prospective, randomized, double-blind study. Spine 1998;23(9):984-98.
55. Rubenthaler 2000 {published data only} *Rubenthaler F, Boluki D, Wittenberg RH. Isotone Kochsalzlösung gegen Lokalanästhetika, Prospektiv randomisierte Doppelblind-studie bei zervikaler Spinalnervenanalgesie. Schmerz 2000;14:92-6.
56. Salzmann 1993 {published data only} *Salzmann VE, Wiedemann O, Loffler L, Sperber H. [Tetrazepam in der behandlung akuter zervikalsyndrome, randomisierte doppleblinde pilotstudie zum vergleich von Tetraepam und plazebo]. Fortschritte der Medizin 1993;34:544-8.
57. San Martin 1978 {published data only} *San Martin J, Roldan A. [Comparacion del eterilato y del acido acetrilsalicilico en el tratamiento de cervicoartrosis: prueba doble ciego]. Archive de Farmacology y Toxicology 1978;4(41):41-6.
58. Sand 1992 {published data only} *Sand T, Bovim G, Held G. Intracutaneous sterile water injections do not relieve pain in cervicogenic headache. Acta Neurologica Scandinavica 1992;86:526- 8.
59. Schnider 2002 15U {published data only} *Schnider P, Moraru E, Vigl M, Wober C, Foldy D, Maly J, et al.Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: a double-blind, randomised placebo-controlled study. Journal of Headache Pain 2002;3:93-9.
60. Schreiber 2001 {published data only} *Schreiber S, Svetiana V, Shavelzon V, Pick CG, Zahavi E, Shir Y. A randomized trial of fluoxetine versus amitriptyline in musculoskeletal pain. Israel Journal Psychiatry Related Science 2001;38(2):88-94.
61. Stav 1993 {published data only} *Stav A, Ovadia L, Sternberg A, Kaadan M, Weksler N. Cervical epidural steroid injection for cervicobrachialgia. Acta Anaesthesiologica Scandinavica 1993;37:562-6.
62. Terzi 2002 {published data only} *Terzi T, Karakurum B, Ucler S, Inan LE, Tulumay C. Greater occipital nerve blockade in migraine, tension-type headache and cervicogenic headache. Journal of Headache Pain 2002;3:137-41.
63. Thomas 1991 {published data only} *Thomas M, Eriksson SV, Lundeberg T. A comparative study of Diazepam and Acupuncture in patients with osteoarthritis pain: A placebo controlled study. American Journal of Chinese Medicine 1991;19(2):95-100.
64. Thomas 1991 (DvAcu) {published data only} refer to Thomas 1991.
65. Thomas 1991 (DvPl) {published data only} refer to Thomas 1991.
66. van Wieringen 2001 {published data only} *van Wieringen S, Jansen T, Smits MG, Nagtegaal JF, Coenen AML. Melatonin for chronic whiplash syndrome with delayed melatonin onset. Clinical Drug Investigation 2001;21(12):813-20.
67. Wheeler 1998 {published data only} *Wheeler AH, Goolkasian P, Gretz SS. A randomized, double-blind prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal myofascial pain syndrome. Spine 1998;23(15):1662-7.
68. Wheeler 1998 (100U) {published data only} refer to Wheeler 1998.
69. Wheeler 1998 (50U) {published data only} refer to Wheeler 1998.
70. Wheeler 2001 (231U) {published data only} *Wheeler AH, Goolkasian P, Gretz SS. Botulinum toxin A for the treatment of chronic neck pain. Pain 2001;94:255-60.
71. Amadio 1985 Amadio P, Cummings DM. The effect of Tolmetin on the chronic pain and decreased functional capacity associated with degenerative joint disease. The Journal of Clinical Pharmacology 1995;25:100-8.
72. Ashina 1999 Ashina M, Bendtsen L, Jensen R, Lassen LH, Sakai F, Olesen J. Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache. Brain 1999;122:1629-35.
73. Barnsley 1993 Barnsley L, Lord S, Bogduk N. Comparative local anaethetic blocks in the diagnosis of cervical zygapophysial joint pain. Pain 1993;55:99-106.
74. Barnsley L, Lord S, Wallis B, Bogduk N. False-Positive rates of cervical zygapophysial joint blocks. The Clinical Journal of Pain 1993;9:124-30.
75. Benach 1980 Benanch JO, Gomez MG, Vallve LC, Barcelo P. Double blind antidepressive (nomifensin) therapeutic test in myotensive cervical syndrome. Revista espanola de reumatisinos y enfermedades osteo-aticulares 1980;23(1):45-63.
76. Bendtsen 2000 Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000;20:603-10.
77. Bensen 2000 Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, et al.Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxin and placebo. The Journal of Rheumatology 2000;27(8):1876-83.
78. Bercel 1977 Bercel NA. Cyclobenzaprine in the treatment of skeletal muscle spasm in osteoarthritis of the cervical and lumbar spine. Current Therapeutic Research 1977;22(4):462-8.
79. Blackie 1990 Blackie JD, Lees AJ. Botulinum toxin treatment in spasmodic torticollis. Journal of Neurology, Neurosurgery, and Psychiatry 1990;53:640-3.
80. Blandino 2001 Blandino D. Are NSAIDs more effective than acetaminophen in patients with osteoarthritis?. The Journal of Family Practice 2001;50(10):894.
81. Bouchier-Hayes 1984 Bouchier-Hayes T. Chlormezanone in low back pain and wry neck - an analgesic sparing effect. The British Journal of Clinical Practice 1984;July/August:259-62.
82. Carlson 1998 Carlson A. NSAIDs improve the quality of sleep in patients with osteoarthritis pain. Geriatrics 1998;53(1):70.
83. Childers 2005 *Childers MK, Borenstein D, Brown RL, Gershon S, Hale ME, Petri M, et al.Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: A randomized trial. Current Medical Research and Opinions 2005;21(9):1485-93.
84. Coeytaux 2005 Coeytaux RR, Kaufman JS, Kaptchuk TJ, Chen W, Miller WC, Callahan LF, Mann D. A randomized, controlled trial of acupuncture for chronic headache. Headache 2005;45:1113-23.
85. Coletta 1988 *Coletta, R. Etofenamate and transcutaneous electrical nerve stimulation treatment of painful spinal syndromes. International Journal of Clinical Pharmacological Research 1988;8(4):295-8.
86. Comella 1992 Comella CL, Buchman AS, Tanner CT, Brown-Toms NC, Goetz CG. Botulinum toxin injection for spasmodic torticollis: Increased magnitude of benefit with electromyographic assistance. Neurology 1992;42:878-82.
87. Crawford 2004 Crawford JR, Khan RJ, Varley GW. Early management and outcome following soft tissue injuries of the neck - a randomised controlled trial. Injury 2004;35:891-5.
88. Evans 2001 Evans TA, Kunkle JR, Zinz KM, Walter JL, Denegar CR. The immediate effects of Lidocaine iontophoresis on trigger-point pain. Journal of Sports Rehabilitation 2001;10:287-97.
89. Evans 2003 *Evans R, Bronfort G, Bittel S, Anderson AV. A pilot study for a randomized clinical trial assessing chiropractic care, medical care, and self-care education for acute and subacute neck pain patients. Journal of Manipulative and Physiological Therapeutics 2003;26:403-11.
90. Gelb 1989 Gelb DJ, Lowenstein DH, Aminoff MJ. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 1989;39:80-4.
91. Giles 2003 *Giles LGF, Muller R. Chronic spinal pain: A randomized clinical trial comparing medication, acupuncture, and spinal manipulation. Spine 2003;28(14):1490-502.
92. Gobel 2001 Goebel H, Heinze A, Ingwersen M, Niederberger U, Gerber D. [Harpagophytum-Extrakt LI174 (Teufelskralle) bei der Behandlung unspezifischer Ruckenschmerzen: Effekte auf die sensible, motorische und vaskulare Muskelreagibilitat]. Schmerz 2001;15:10-8.
93. Goldstein 2001 Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, et. al. Reduced incidence of gastroduodenal ulcers with celecoxib, a noval cyclooxygenase-2 inhibitor, compared to naproxin in patients with arthritis. American Journal of Gastroenterology 2001;96(4): 1019-27.
94. Hameroff 1982 Hameroff SR, Cork RC, Scherer K, Crago BR, Neuman C, Womble JR, et al.Doxepin effects on chronic pain, depression and plasma opiods. Journal of Clinical Psychiatry 1982;43(8 [Sedc2]):22-7.
95. Hashimoto 1977 Hashimoto T, Ishihara M, Yoshida T, et al.Clinical evaluation of Protizinic acid on diseases in orthopaedics - Double blind controlled study on neck, shoulder, and arm pain compared with Mepirizole. Clinical Evaluation 1977;5(1):55-82.
96. Hawkey 1998 Hawkey C, Kahan A, Steinbruck K, Alegre C, Baumelous E, Begaud B, et al.Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. Journal of Rheumatology 1998;37:937-45.
97. Hawkey 2000 Hawkey C, Laine L, Simon T, Beaulieu A, Maldonado-Cocco J, Acevedo E, et al.Comparison of the effect of rofecoxib (a cyclooxygnase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis. Arthritis and Rheumatism 2000;43(2):370-7.
98. Horvath 1969 *Horvath J, Fellman N. [Behandlungsergebnisse mit Nifluril im doppelten Blindversuch bei degenerativen zervikalen Veranderungen mit oder ohne Zervikalsyndrom]. Praxis 1969;58(42): 1342-5.
99. Howe 1983 Howe DH, Newcombe RG, Wade MT. Manipulation of cervical spine - a pilot study. Journal of the Royal College of General Practitioners 1983;33:574-9.
100. Ilbuldu 2004 Ilbuldu E, Cakmak A, Disci R, Aydin R. Comparison of laser, dry needling, and placebo laser treatments in myofascial pain syndrome. Photomedicine and Laser Surgery 2004;22(4):306-11.
101. Iwama 2001 Iwama H, Ohmori S, Kaneko T, Watanabe K. Water-diluted local anesthetic for trigger-point injection in chronic myofascial pain syndrome: Evaluation of types of local anesthetic and concentrations in water. Regional Anesthesia and Pain Medicine 2001;26(4):333-6.
102. Jankovic 1987 Jankovic J, Orman J. Botulinum-A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 1987;37:616-23.
103. Jovicic 1991 Jovicic A, Ivanisevic V. [Primena tetraepama u lecenju bolnih misicnih spazama]. Vojnosanitetski Pregled 1991;48(5):394-9.
104. Khare 1994 Khare GN. The biological factors in the etiopathogenesis and management of cervical spondylosis. Indian Journal of Medical Sciences 1994;48:1-5.
105. Koller 1990 Koller W, Vetere-Overfield B, Gray C, Dubinsky R. Failure of fixed-dose, fixed muscle injection of Botulinumtoxin in torticollis. Clinical Neuropharmacology 1990;13(4):355-8.
106. Kotani 1976 *Kotani T, Ichikawa N. A double blind controlled study on the clinical efficacy of anti-inflammatory analgesic, 31252-S on Orthopaedics. Clinical Evaluation 1976;3(2):189-211.
107. Laine 1999 Laine L, Harper S, Simon T, Bath R, Johanson J, Schwartz H, et al.A randomized trial comparing the effect of Rofecoxib, a Cyclooxygenase 2-specific inhibitor, with that of Ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology 1999;117:776-83.
108. Lange 1991 Lange DJ, Rubin M, Greene PE, Kang UJ, Moskowitz CB, Brin MF, et al.Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes. Muscle and Nerve 1991;14:672-5.
109. Lee 2001 Lee SC, Han TH. Clinical efficacy and safety of slow-release tramadol for chronic osteoarthritis in an outpatient pain clinic. European Journal of Pain 2001;5 (Suppl. A):131.
110. Lew 1997 Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, et al.Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 1997(49):701-7.
111. Lew 2002 Lew MF. Botulinum toxin type B: An effective treatment for alleviating pain associated with cervical dystonia. Journal of Back and Musculoskeletal Rehabilitation 2002;16:3-9.
112. Li 2001 Li JX, Xiang CJ, Liu XQ. Clinical study on analgesic mechanism of bitongxiao in treating neck pain due to cervical spondylitis. [Chinese] Treatment of spinal-cord-type cervical spondylosis by Chinese massotherapy. Chinese Journal of Integrated Traditional & Western Medicine 2001;21(7):516-8.
113. Lord 1995 Lord SM, Barnsley L, Bogduk N. The utility of comparative local anesthetic blocks versus placebo-controlled blocks for the diagnosis of cervical zygapophysial joint pain. The Clinical Journal of Pain 1995;11:208-13.
114. Lord 1996 Lord S, Barnsley L, Wallis BJ, Bogduk N. Chronic cervical zygapophysial joint pain after whiplash: A placebo-controlled prevalence study. Spine 1996;21(15):1737-44.
115. Lu 1995 Lu ChS, Chen RS, Tsai ChH. Double-blind, placebo controlled study of botulinum toxin injections in the treatment of cervical dystonia. Journal of the Formosan Medical Association 1995;94(4):189-92.
116. Lundeberg 1991 Lundeberg T, Eriksson SV, Lundeberg S, Thomas M. Effect of acupuncture and naloxone in patients with osteoarthritis pain. A sham acupuncture controlled study. The Pain Clinic 1991;4(3):155-61.
117. McCleane 2000 McCleane G. The addition of piroxicam to topically applied glyceryl trinitrate enhances its analgesic effect in musculoskeletal pain: a randomized, double-blind, placebo-controlled study. The Pain Clinic 2000;12(2):113-6.
118. Miehle 2001 Miehle W. Leflunomid (Arava). Internistische Praxis 2001;41(1):155-62.
119. Minisola 1987 Minisola G, Porzio F, Minisola S, Accardi L, Delorenzi G, Trezzi P. Action of oral and rectal preparations of flurbiprofenin arthrosis. Clinical and Experimental 1987;42:1026-32.
120. Minisola 1989 Minisola G, Dardano B. [Piroxicame cervico-tomboartrosi]. La Clinica Terapeutica 1989;131:73-82.
121. Miranda 1997 Miranda RG. Treatment of musculoskeletal lesions in sports men with a topical anti-inflammatory: diehylammonium diclofenac. Comparative double blind study. Compendiumde investigaciones clinicas latinoamericanas 1997:3-18.
122. Montrone 2000 Montrone F, Santandrea S, Caruso I, Gerli R, Cesarotti MEF, Frediani PV, et al.Amtolmetin Guacyl versus Piroxicam in patients with osteoarthritis. The Journal of International Medical Research 2000;28:91-100.
123. Moore 1999 Moore N, Van Ganse E, LeParc JM, Wall R, Schneid H, Farhan M, et al.The PAIN study: Paracetamol, aspirin and ibuprofen new tolerability study; A large-scale, randomized clinical trial comparing the tolerability of aspirin, Ibuprofen and paracetamol for short-term analgesia. Clinical Drug Investigation 1999;18(2):89-98.
124. Naumann 2002 Naumann M, Yakovleff A, Durif F, Botox Cervical Dystonia Prospective Study Group. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia. Journal of Neurology 2002;249:57-63.
125. Neubauer 1983 Neubauer VM, Bach GL. [Kurzzeittherapie schmerzhafter muskularer Beschwerden]. Fortschritte der Medizin 1983;101(21):1009-13.
126. Nikles 2000 Nikles CJ, Glasziou PP, Del Mar CB, et al.Primary experiences with a single-patient trials service general practice. The Medical Journal of Australia 2000;173:100-3.
127. Poewe 1998 Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, et al.What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia: Results of a double blind, placebo controlled, dose ranging study using Dysport. Journal of Neurology, Neurosurgery and Psychiatry 1998;64:13-7.
128. Porta 1999 Porta M. Botulinum toxin type A injections for myofascial pain syndrome and tension-type headache. European Journal of Neurology 1999;Suppl 6(4):103-9.
129. Porta M, Loiero M, Gamba M, Luccarelli G, Fornari M. The use of botuline A toxin in the treatment of myofascial painful syndromes [L'impiego della tossina botulinica tipo A* nelle sindromi dolorose miofaxciali]. La Riabilitazione 1999;32(2):49-55.
130. Porta 2000 Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment ofmyofascial pain syndrome and pain from chronic muscle spasm. Pain 2000;85:101-5.
131. Porto 1998 Porto A, Reis C, Perdigoto R, Goncalves M, Freitas P, Macciocchi A. Gastroduodenal tolerability of nimesulide and diclofenac in patients with osteoarthritis. Current Therapeutic Research 1998;59(9):654-65.
132. Pratzel 1993 Pratzel HG, Leglar B, Aurand K, Baumann K, Franke Th. [Wirksamkeitsnachweis von Radonbadern im Rahmen einer kurortmedizinischen Behandlung des zervikalen Schmerzsyndroms]. Phys Rehab Kur Med 1993;3:76-82.
133. Ranoux 2001 Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M. Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. Journal of Neurology, Neurosurgery, and Psychiatry 2002;72:459-62.
134. Reginster 2001 Reginster JY, Leroisy R, Rovati LC. Does glucosamine sulfate affect progression of symptoms and joint structure changes in osteoarthritis?. The Journal of Family Practice 2001;50(5):394.
135. Roth 2000 Roth SH, Fleischmann RM, Burch FX, Dietz F, Bockow B, Rapoport RJ, et al.Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain. Archives Internal Medicine 2000;160:853-60.
136. Sampaio 1997 Sampaio C, Ferreira JJ, Simoes F, Rosas MJ, Magalhaes M, Correia AP, et al.DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of Botulinum Toxin Type A - Dysport and Botox - assuming a ratio of 4:1. Movement Disorders 1997;12(6):1013-8.
137. Schmid 2000 Schmid B, Ludtke R, Selbmann HK, Kotter I, Tschirdewahn B, Schaffner W, et al.Effectiveness and tolerance of standardized willow bark extract in arthrosis patients. Randomized, placebo controlled double-blind study [Weidenrindenextrakt bei Arthrose]. Zeitschrift für Rheumatologie 2000;59(5):314-20.
138. Schmitt 1968 Schmitt HW. [Zur behandlung des zervikalen Schmerzsyndroms]. Die Medizinische Welt 1968;May 4(180):1196-8.
139. Schmitt 1999 Schmitt W, Walter K, Kurth HJ. Clinical trial on the efficacy and safety of different diclofenac formulations: Multiple-unit formulations compared to enteric coated tablets in patients with activated osteoarthritis. Inflammopharmacology 1999;7(4):636-75.
140. Schnabel 2004 *Schnabel M, Ferrari R, Vassiliou T, Kaluza G. Randomised, controlled outcome study of active mobilisation compared with collar therapy for whiplash injury. Emergency Medicine Journal 2004;21:306-10.
141. Shah 2001 Shah A, Woodruff M, Agarwal V, Liu P, Sundaresan P. Pharmacokinetics, safety, and tolerability of BAY 12-9566 and nonsteroidal antiinflammatory agents (naproxen, ibuprofen) during coadministration in patients with osteoarthritis. Journal Clinical Pharmacology 2001;41:330-9.
142. Shakoor 2002 Shakoor MA, Ahmed MS, Kibria G, Khan AA, Mian MAH, Hasan SA, et al.Effects of cervical traction and exercise therapy in cervical spondylosis. Bangladesh Medical Research Council Bulletin 2002;28(2):61-9.
143. Silberstein 2000 Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum Toxin Type A as a migraine preventive treatment. Headache 2000;40:445-50.
144. Silverstein 2000 Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al.Gastrointenstinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. Journal American Medical Association 2000;284(10):1247-55.
145. Smuts 1999 Smuts JA, Backer MK, Smuts HM, Strassen JM, Rossouw E, Barnhard WA. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. European Journal of Neurology 1999;Suppl 6(4):99-102.
146. Truitt 2001 Truitt KE, Sperling RS, Ettinger WH, Greenwald M, DeTora L, Zeng Q, et al.A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis. Aging Clinical Experimental Research 2001;13:112-21.
147. Tschopp 1996 Tschopp KP, Gysin C. Local injection therapy in 107 patients with myofascial pain syndrome of the head and neck. Journal of Oto-Rhino-Laryngology & its Related Specialties 1996;58:306-10.
148. Tsui 1986 Tsui JKC, Eisen A, Stoessl AJ, Calne S, Calne DB. Double-blind study of botulinum toxin in spasmodic torticollis. The Lancet 1986; August 2:245-7.
149. Turturro 1998 Turturro MA, Paris PM, Larkin GL. Tramadol Versus Hydrocodone-Acetaminophen in acute musculoskeletal pain: A randomized, double-blind clinical trial. Annals of Emergency Medicine 1998;32:139-43.
150. van Cauwenberge 1986 van Cauwenberge-Ruhwiedel MV, Cauwenberge HV. Preliminary study of the efficiency and tolerance of a new NSAID SPA-S-510, in osteoarthrosis. A controlled double-blind study versus piroxicam. Riv It Biol Med 1996;6:181-6.
151. Verbruggen 1982 *Verbruggen LA, Cytryn E, Pintens H. Double-blind crossover study of Nabumetone versus Naproxen in the treatment of osteoarthritis. The Journal of International Medical Research 1982;10:214-8.
152. Viara 1986 Viara M, Nebiolo M, Michos N, Sarchi C. Double-blind placebo-controlled study of the efficacy and tolerability of suprofen suppositories in patients with osteoarthritic pain. Arzneimittel-Forschung 1986;36(7):1113-5.
153. Walach 2003 Walach H, Guthlin C, Konig M. Efficacy of massage therapy in chronic pain: A pragmatic randomized trial. Journal of Alternative and Complementary Medicine 2003;9(6):837-46.
154. Wallace 1994 Wallace JD. Summary of combined clinical analysis of controlled clinical trials with tizanidine. Neurology 1994;44:60-9.
155. Whitaker 2001 Whitaker J, Butler A, Semlyen JK, Barnes MP. Botulinum Toxin for people with dystonia treated by an outreach nurse practitioner: A comparative study between a home and a clinic treatment service. Archives Physical Medicine and Rehabilitation 2001;82:480-4.
156. Wilder-Smith 2001 Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain for osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAIDs: a randomized study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001;91:23-31.
157. Bronfort 2000 Conservative Treatment for Neck Pain: A Pilot Study. Ongoing study Starting date of trial not provided. Contact author for more information.
158. Bronfort 2002 Chiropractic, Medication, and Self-care for Neck Pain Phase II trial. Ongoing study This study is currently recruiting patients.
159. Dartmouth 2002 Pilot study of spinal manipulation for chronic neck pain. Ongoing study no longer recruiting.
160. Stokke 1995 A randomised comparison of chiropractic and physiotherapy treatment for neck pain of functional (mechanical) origins. A controlled clinical trial. Ongoing study Starting date of trial not provided. Contact author for more information.
161. Tanaka 1995 Chiropractic therapy compared to medical therapy for chronic cervical pain. Ongoing study start: Nov 1994 complete: June 1995.
162. Aker 1996 Aker PD, Gross AR, Goldsmith CH, Peloso P. Conservative management of mechanical neck pain: A systematic overview and meta-analysis. British Medical Journal 1996;313:1291-6.
163. Borenstein 1998 Borenstein DG. Management of neck pain: a primary care approach. Hospital Practice (Office Ed.) 1998;33(10):147-50, 153-4, 160.
164. Bovim 1994 Bovim G, Schrader H, Sand T. Neck pain in the general population. Spine 1994;19:1307-9.
165. Brattberg 1989 Brattberg G, Thorslund M, Wikman A. The prevalence of pain in a general population. The result of a postal survey in the country of Sweden. Pain 1989;37:215-22.
166. Browning 2001 Browning R, Jackson JL, O'Malley PG. Cyclobenzaprine and back pain: a meta-analysis. Archives of Internal Medicine 2001;161(13):1613-20.
167. Cassidy 2000 Cassidy JD, Carroll LJ, Cote P, Lemstra M, Berglund A, Nygren A. Effect of eliminating compensation for pain and suffering on the outcome of insurance claims for whiplash injury. New England Journal of Medicine 2000;342(16):1179-86.
168. Cicchetti 1976 Cicchetti DV. Assessing inter-rater reliability for rating scales: resolving some basic issues. British Journal of Psychiatry 1976;129:452-6.
169. Cohen 1988 Cohen J. Statistical power analysis for the behavioural sciences. 2nd Edition. Hilldale, NJ: Lawrence Erlbaum Associates, 1988.
170. Croft 2001 Croft PR, Lewis M, Papageorgiou AC, Thomas E, Jayson MI, Macfarlane GJ, et al.Risk factors for neck pain: a longitudinal study in the general population. Pain 2001;93(3):317-25.
171. Côté 1998 Côté P, Cassidy D, Corroll L. The Saskatchewan health and back pain survey. The prevalence of neck pain and related disability in Saskatchewan adults. Spine 1998;23(5):1689- 98.
172. Côté 2000 Côté P, Cassidy JD, Carroll L. The factors associated with neck pain and its related disability in the Saskatchewan population. Spine 2000;25(9):1109-17.
173. Côté 2001 Côté P, Cassidy JD, Carroll L. The treatment of neck and low back pain: who seeks care? who goes where?. Medical Care 2001;39(9):956-67.
174. Dupont 1990 Dupont WD, Plummer WD. Power and sample size calculations: A review and computer program. Controlled Clinical Trials 1990;11:116-8.
175. Farrar 2001 Farrar JT, Young JP Jr, La Moureaux L, Worth JL, Poole RM. Clinical Importance of Changes in Chronic Pain Intensity Measured on an 11-point numerical rating scale. Pain 2001;94:149-58.
176. Felson 1995 Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al.American College of Rheumatology: Preliminary definition of improvement in rheumatoid arthritis. Arthritis and Rheumatism 1995;38(6):727-35.
177. Gross 1996 Gross AR, Aker PD, Goldsmith CH, Peloso P. Conservativemanagement of mechanical neck disorders: A meta-analysis. Online Journal of Current Clinical Trials [serial online] 1996;July 30:Doc No 200 and 201.
178. Gross 2002 Gross AR, Kay T, Hondras M, Goldsmith C, Haines T, Peloso P et.al. Manual therapy for mechanical neck disorders: a systematic review. Manual Therapy 2002;7(3):131-49.
179. Gross 2003 Gross A, Goldsmith C, Kay T, Haines T, Peloso P, Kroeling P, et al.Conservative management of mechanical neck disorders: A series of systematic reviews. Association of Chiropractic Colleges and Research Agenda Conference; 2003 Conference / New Orleans, LA. March 13-16, 2003:29.
180. Hackett 1987 Hackett GI, Hudson MR, Wyle JB, Jackson AD, Small KM, Harrison P, et al.Evaluation of the efficacy and acceptability to patients of physiotherapy working in a health centre. British Medical Journal 1987;294(6563):24-6.
181. Jadad 1996 Jadad AR, Moore RA, Corroll D, Jenkinson C, Reynolds DJ, Gavagha DJ, McQuary HJ. Assessing the quality of reports of randomized controlled trials: Is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
182. Jamison 1998 Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. Spine 1998;23(23):2591-600.
183. Katz 2003 Katz N, Ju WD, Krupa DA, Sperling RS, Bozalis RD, Gertz BJ, et al.Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. Spine 2003;28(9):851-9.
184. Kendal 1963 Kendal MG, Stuart A. The advanced theory of statistics: Distribution theory. 2nd Edition. Vol. 1, New York: Hofner Publishing Co, 1963.
185. Kvarnstrom 1983 Kvarnstrom S. Occurrence of musculoskeletal disorders in a manufacturing industry with special attention to occupational shoulder disorders. Scandinavian Journal of Rehabilitation Medicine 1983;Suppl 8:1-114.
186. Lamberts 1987 Lamberts H, Brouwer H, Groen AJM, Huisman H. [Het transitiemodel in de huisartspraktijk]. Huisarts en Wetenschap 1987;30:105-13.
187. Lavis 1998 Lavis JN, Malter A, Anderson GM, Taylor VM, Deyo RA, Bombardier C, et al.Trends in hospital use for mechanical neck and back problems in Ontario and the United States: discretionary care in different health care systems. Canadian Medical Association Journal 1998;158(1):29-36.
188. Lawrence 1969 Lawrence JS. Disc degeneration: its frequency and relationship to symptoms. Annals of the Rheumatic Diseases 1969;28:121-37.
189. Light 1984 Light RJ, Pillemer DB. Summing up: the science of reviewing research. Cambridge MA: Harvard University Press, 1984.
190. Linton 1998 Linton SJ, Hellsing Al, Hallden K. A population-based study of spinal pain among 35-45 year old individuals. Prevalence, sickleave, and health care use. Spine 1998;23(13):1457-63.
191. Little 1984 Little RJA, Ruben DV. Statistical Analysis with Missing Data. New York: John Wiley, 1987.
192. Makela 1991 Makela M, Heliovaara M, Sievers K, Impivaara O, Knekt P, Aromaa A. Prevalence determinants and consequences of chronic neck pain in Finland. American Journal of Epidemiology 1991;134:1356-67.
193. Olesen 1988 Olesen J. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalagia 1988;8(7):61-2.
194. Olesen 1997 Olesen J, Gobel H. ICD-10 Guide for Headaches. Guide to the classification, diagnosis and assessment of headaches in accordance with the tenth revision of the International classification of diseases and related health problems and its application to neurology. Cephalagia 1997;17(Suppl 19):29-30.
195. Palmer 2001 Palmer KT, Walker-Bone K, Griffin MJ, Syddall H, Pannett B, Coggon D, et al.Prevalence and occupational associations of neck pain in the British population. Scandinavian Journal of Work, Environment & Health 2001;27(1):49-56.
196. Radanov 1994 Radanov BP, Sturzenegger M, DeStefano G, Schindrig A. Relationship between early somatic, radiological, cognitive, and psychosocial findings and outcome during a one-year follow-up in 117 patients suffering from common whiplash. British Journal of Rheumatology 1994;33:442-8.
197. Rajala 1995 Rajala U, Keinanen-Kiukanniemi S, Uusimaki A, Kivela S-L. Muscoloskeletal pains and depression in a middle-aged Finnish population. Pain 1995;61:451-7.
198. Royal College 1980-1 Royal College of General Practicioners. Third national morbidity survey in general practice. Office of population censuses and surveys, Department of Health and Social Security 1980-1; Vol. Series MB5 (1).
199. Rush 1994 Rush PJ, Shore A. Physician perceptions of the value of physical modalities in the treatment ofmusculoskeletal disease. British Journal of Rheumatology 1994;33:566-8.
200. Sackett 2000 Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine: How to Practice and Teach EBM. 2nd Edition. Edinburgh: Churchill Livingstone, 2000.
201. Salerno 2002 Salerno SM, Browning R, Jackson JL. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Archives Internal Medicine 2002;162(1):19-24.
202. Schumacher 1993 Schumacher HR, Klippel JH, Koopman WD (eds). Primer on the Rheumatic Diseases. 10th Edition. Atlanta: Arthritis Foundation, 1993.
203. Sjaastad 1990 Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. Headache 1990;30:725- 6.
204. Spitzer 1987 Spitzer WO, Leblanc FE, Dupuis M. Scientific approach to the assessment and management of activity related spinal disorders. Spine 1987;7:S1-59.
205. Spitzer 1995 Spitzer WO, Skovron ML, Salmi LR Cassidy JD, Duranceau J, Suissa S, et al.Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management. Spine 1995;Suppl 20:1-73.
206. Stratford 1999 Stratford PW, Riddle DL, Binkley JM, Spadoni G, Westaway MD, Padfield B. Disability Index to make decisions concerning individual patients. Physiotherapy Canada 1999;Spring:107-19.
207. Sutton 2002 Sutton AJ, Abrahms KR, Jones DR, Sheldon TR, Song F. Methods for meta-analysis in medical research: Missing data, Chapter 13. Toronto, ON: John Wiley and Sons, 2002:199-204.
208. Tollison 1992 Tollison CD, Satterthwaite JR, editors. Painful cervical trauma: diagnosis and rehabilitative treatment of neuromusculoskeletal injuries. Baltimore MD: Williams & Wilkins, 1992.
209. Urwin 1999 Urwin M, Symmons D, Allison T, Brammah T, Busby H, Roxby M, et al.Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Annals of the Rheumatic Diseases 1999;57(11):649-55.
210. van Tulder 2000 van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Nonsteroidal antiinflammatory drugs for lowback pain: A systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2000;25(19):2501-13.
211. van Tulder 2003 van Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003;28(12):1290-9.
212. Waalen 1994 Waalen D, White P, Waalen J. Demographic and clinical characteristics of chiropractic patients: A five year study of patients treated at the Canadian Memorial Chiropractic College. Journal of Canadian Chiropractic Association 1994;38:75-82.
213. Peloso 2004 Peloso P, Gross A, Haines T, Trinh K, Goldsmith CH, Aker P, Cervical Overview Group. Medicinal and Injection therapies for mechanical neck disorders. Cochrane Database of Systematic Reviews 2004, Issue 2.Art. No.: CD000319. DOI: 10.1002/14651858.CD000319.pub3.